SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (20051)5/5/1998 8:18:00 AM
From: tonyt  Respond to of 32384
 
>Henry but one thing the extra coverage will do is insure that LGND's NDA
>and others worthy of expedited review will get moved more quickly thru the system.

Well, it does help if they file it first.



To: bob zagorin who wrote (20051)5/5/1998 8:29:00 AM
From: Henry Niman  Respond to of 32384
 
bob, Although in depth news coverage on new cancer treatments has been somewhat lacking, the widespread coverage will renew demands for quick approval of promising drugs. Public pressure did speed up treatments for AIDS and I expect a similar result for cancer drugs.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News